Latest News for: wet amd

Edit

Ocular Therapeutix™ Announces Plans to Accelerate NDA Submission Timeline for AXPAXLI™ in Wet AMD

Nasdaq Globe Newswire 08 Dec 2025
Ocular intends to submit AXPAXLI New Drug Application (NDA) for wet AMD shortly after year one data from SOL-1, if positive ... .
Edit

4DMT Announces Positive Long-Term Data from Phase 1/2 PRISM Clinical Trial in Wet AMD

Enid News & Eagle 06 Nov 2025
4D-150 demonstrated consistent and durable benefit ...
Edit

4DMT Announces Positive Long-Term Data from Phase 1/2 PRISM Clinical Trial in Wet AMD Supporting ...

Nasdaq Globe Newswire 06 Nov 2025
... 1/2 PRISM clinical trial evaluating 4D-150 in patients with wet age-related macular degeneration (wet AMD).
Edit

4D-150 Business & PRISM Wet AMD Long-term Data Update (46f46c) (4D Molecular Therapeutics Inc)

Public Technologies 06 Nov 2025
Wet AMD Long-term Data Update ... Retina Specialists Are Excited to Utilize Gene Therapy for Wet AMD ... POSITIVE WET AMD CLINICAL DATA ... PRISM Phase 1/2 Clinical Trial in Wet AMD ... and across diverse wet AMD disease activity populations..
Edit

Wet-AMD Pipeline Outlook Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight

GetNews 11 Oct 2025
Inactive Products Wet Age-Related Macular Degeneration (Wet-AMD) Key Companies Wet Age-Related Macular Degeneration (Wet-AMD) Key Products Wet Age-Related Macular Degeneration (Wet-AMD)- Unmet Needs ...
Edit

REGENXBIO Announces Completion of Enrollment in Pivotal Trials of Subretinal Surabgene Lomparvovec for Wet AMD

The Galveston Daily News 06 Oct 2025
... wet AMDTopline pivotal data expected in Q4 2026 ....
  • 1

Article Search

tools
×
×
×
×